Welcome to the Oncology Brothers podcast! In this episode, we discussed the current treatment landscape for prostate cancer, featuring special guest Dr. Scott Tagawa, a GU Medical Oncologist from Weill Cornell Medicine.

Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Follow us on social media:

X/Twitter: https://twitter.com/oncbrothers
Instagram: https://www.instagram.com/oncbrothers
Website: https://oncbrothers.com/

Join us as we explored:

The current standard of care for localized prostate cancer, including active surveillance, surgery, and radiation.
The significance of ADT and abiraterone in high-risk disease, supported by the STAMPEDE trial.
The role of PSMA PET/CT in staging and how it impacts treatment decisions.
Treatment options for castration-sensitive and castration-resistant prostate cancer, including the use of ARPi and chemotherapy.
The importance of germline and somatic testing, especially with the recent approval of Niraparib for BRCA2-positive disease.
Insights on managing side effects and the nuances of patient-centered care in oncology.

Whether you're a healthcare professional or someone interested in the latest advancements in cancer treatment, this episode is packed with valuable information to help you stay informed.

Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!

#ProstateCancer, #ADT, #PSMA, #PARPinhibitor, #OncologyBrothers

How to Treat Prostate Cancer Localized to Advanced Settings - Dr. Scott Tagawa

Oncology Brothers: Practice-Changing Cancer Discussions

How to Treat Prostate Cancer Localized to Advanced Settings - Dr. Scott Tagawa